T-Cell Engager Therapy in Prostate Cancer: Molecular Insights into a New Frontier in Immunotherapy. [PDF]
Kwon WA, Joung JY.
europepmc +1 more source
In situ biomimetic materials for dentin repair
This review primarily discusses the role and clinical application of key biomimetic materials for in situ dentin repair, providing a feasible foundation for future material and performance optimization in situ dentin regeneration. Abstract Dental defects, ranking among the most prevalent diseases globally, pose a serious threat to human health, with ...
Jingjing Deng +3 more
wiley +1 more source
A comprehensive strategy for pandemic preparedness with neutralizing monoclonal antibodies. [PDF]
Marx C +5 more
europepmc +1 more source
Three biobased membranes are synthesized by crosslinking oxidized Kraft lignin with poly(ethylene glycol) diglycidyl ether of increasing molecular weights. After incorporation of solvated potassium salts, potassium batteries including these biobased gel polymer electrolytes are able to deliver a maximum specific capacity at 0.05 A g−1 as high as 130 ...
Giuseppe Pascuzzi +5 more
wiley +1 more source
Harnessing chimeric antigen receptor macrophages against solid tumors
Abstract Macrophages are prevalent in multiple tumors and exhibit diverse and potent functional activities. Therapeutic reprogramming of macrophage phenotypes represents a promising strategy for cancer immunotherapy. Engineering chimeric antigen receptors (CARs) to endow macrophages with anti‐tumor capacities demonstrated encouraging efficacy ...
Mengru Wang +3 more
wiley +1 more source
An Enhanced Bimetallic Optical Fiber SPR Biosensor Using Graphene Oxide for the Label-Free and Sensitive Detection of Human IgG. [PDF]
Xu Q, Yin H, Cui M, Huang R, Su R.
europepmc +1 more source
Long-Circulating Nanobody Confers Durable Prophylaxis against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Infection. [PDF]
Vaskuri GJ +9 more
europepmc +1 more source
YAbS: The Antibody Society's antibody therapeutics database. [PDF]
Rawat P +5 more
europepmc +1 more source
Tislelizumab: Structural Innovations and Expanding Clinical Horizons in Next-Generation PD-1 Immunotherapy. [PDF]
Nguyen TT +4 more
europepmc +1 more source

